Noticeably, these effects were blocked if in the absence of lincRNA-p21-induced PTEN enhancement, and these circumstances demonstrate the fact that lincRNAp21 inhibits liver fibrosis through PTEN. This evidence concerns the gene CDKN1A and Hepatic fibrosis.